HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Post-Pandemic Stocks

878.414

-11.994-1.35%

Number of Gainers:- -

Number of Losers:17

Number of Flat:- -

PE:- -

High:889.460

Open:889.460

Low:870.070

Close:890.408

Volume:127.55M

Turnover:884.95M

Market Cap:592.95B

Float Cap:491.82B

Loading ...

China Traditional Chinese Medicine Says NMPA Approves Launch of Xingpi Jieyu Tablets for Depression

China Traditional Chinese Medicine Holdings - Nmpa Approves Xingpi Jieyu Tablets for Marketing

THOMSON REUTERS

Sinopharm Group Stock Advances 1.5% in Hong Kong

JD Health International Stock Rallies 2.9% in Hong Kong

Alibaba Health Information Technology Stock Climbs 3.3% in Hong Kong

DBS lifts BYD Electronic price target to HK$40, reiterates 'Buy'

Healthcare Sector Poised for Continued Recovery, Buoyed by Strong Innovation and Upgraded Earnings Forecasts

Hong Kong Stock Exchange Data Reveals Significant Custody Transfer for GENFLEET-B

Sino Biopharma Gets US FDA Investigational New Drug Approval for Tumor Drug

MT Newswires Live

Baiyunshan Announces Cash Dividend Distribution for First Half of 2026

Sino Biopharm Says FDA Clears IND for Tqb6426 GPC3 ADC Trial in Advanced Tumors

Sino Biopharmaceutical - Application for Clinical Trial on Tqb6426 "Gpc3 ADC" Approved by FDA

THOMSON REUTERS

Executive Wang Lei Boosts Stake in China Resources Mixc Lifestyle with Fresh Share Purchase

GENFLEET-B Allocates HK$546,400 to Buy Back 20,000 Shares on September 3

Shanghai Fosun Pharma - Drug Registration Application for Additional Indication of Luvometinib Tablets of Unit Approved by Nmpa China

THOMSON REUTERS

Sihuan Pharma Affiliate Xuanzhu Biopharm Grants Innobic Exclusive Thailand Commercialization Rights for Bireociclib Tablets

CSPC Pharmaceutical Group Stock Climbs 4.8% in Hong Kong

Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors

BYD Electronic (International) Stock Falls 3.1% in Hong Kong

Shanghai Fosun Pharmaceutical Secures Regulatory Nod for Expanded Use of Lung Cancer Drug

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.atigrnexa.com/stock/BK1515/news?page=5"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"BK1515","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","market":"HK","secType":"PLATE","nameCN":"Post-Pandemic Stocks","latestPrice":878.41425,"timestamp":1789098783562,"preClose":890.4082,"halted":0,"volume":127553716,"delay":0,"changeRate":-0.01347,"floatShares":0,"shares":0,"eps":0,"marketStatus":"Trading","change":-11.993958,"latestTime":"09-11 11:53:04","open":889.45984,"high":889.45984,"low":870.06995,"amount":884947989,"amplitude":0.021776,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"tradingStatus":0,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1789099200000},"marketStatusCode":0,"adr":0,"adjPreClose":0,"openAndCloseTimeList":[[1789090200000,1789099200000],[1789102800000,1789113600000]],"pbRate":1.335759,"peRate":17.310205,"turnoverRate":0.001747,"increases":0,"decrements":17,"flats":0,"marketCap":592951790336,"floatMarketCap":491823959424},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"BK1515\",,,,,undefined,":{"symbol":"BK1515","high":889.45984,"amplitude":0.021776,"preClose":890.4082,"low":870.06995,"pbRate":"1.335759","latestPrice":878.41425,"volume":127553716,"delay":0,"open":889.45984,"prevYearClose":1190.107,"prevWeekClose":936.431,"prevMonthClose":925.265,"prevQuarterClose":802.777,"fiveDayClose":936.431,"twentyDayClose":912.416,"sixtyDayClose":852.523,"secType":"PLATE","market":"HK","turnoverRate":0.001747,"peRate":17.310205,"marketCap":592951790336,"floatMarketCap":491823959424,"timestamp":1789098783562,"nameCN":"Post-Pandemic Stocks"},"@#url:\"https://hq.skytigris.cn/api/global/plate/up_down\",method:\"POST\",data:#delay:false,bkCodes:@\"BK1515\",,,,undefined,":{"bkCode":"BK1515","up":0,"down":17,"flat":0},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"BK1515\",pageSize:20,pageCount:5,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2664334921","title":"China Traditional Chinese Medicine Says NMPA Approves Launch of Xingpi Jieyu Tablets for Depression","url":"https://stock-news.laohu8.com/highlight/detail?id=2664334921","media":"Reuters","labels":["shareholding","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664334921?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:46","pubTimestamp":1788525998,"startTime":"0","endTime":"0","summary":"China Traditional Chinese Medicine says NMPA approves launch of Xingpi Jieyu tablets for depressionChina Traditional Chinese Medicine Holdings said China’s NMPA cleared its Class 1.1 TCM innovative dr","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nNDL6dF7Rm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1191","BK1515","00570","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664349413","title":"China Traditional Chinese Medicine Holdings - Nmpa Approves Xingpi Jieyu Tablets for Marketing","url":"https://stock-news.laohu8.com/highlight/detail?id=2664349413","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664349413?lang=en_us&edition=fundamental","pubTime":"2026-09-04 20:46","pubTimestamp":1788525987,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260904:nFWN44W0SO:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["00570","BK1515","BK1191","BK1606"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803133","title":"Sinopharm Group Stock Advances 1.5% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803133","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803133?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:33","pubTimestamp":1788510780,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sinopharm Group Co. Ltd. advanced 1.5% to 15.69 Hong Kong dollars on what proved to be an all-around great trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 25650.87.This was the stock's second consecutive day of gains.Sinopharm Group Co. Ltd. closed 30% below its 52-week high of HK$22.34, which the company achieved Feb. 25.The stock outperformed some of its competitors, as Shanghai Fosun Pharmaceutical  Co. Ltd. rose 0.4%.Trading volume totaled 9.2 million shares, compared to the 50-day average of 5.2 million shares.Data source: Dow Jones Market Data, FactSet","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0096","BK0175","BK1593","BK0239","BK1197","BK0188","BK0196","BK0012","BK1515","BK1191","SHTDY","02196","BK0183","600196","01099","LU1115378108.SGD","BK0187","BK4175","BK0060","BK0028","LU0640798160.USD","BK1500"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664138039","title":"JD Health International Stock Rallies 2.9% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664138039","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664138039?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:32","pubTimestamp":1788510720,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of JD Health International Inc. advanced 2.9% to 37.06 Hong Kong dollars on what proved to be an all-around favorable trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 25650.87.JD Health International Inc. closed 48% below its 52-week high of HK$71.70, which the company achieved Jan. 15.Trading volume totaled 7.4 million shares, compared to the 50-day average of 10.0 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1247","BK1589","SGXZ62798434.SGD","LU0051755006.USD","BK1583","BK1142","06618","BK1615","LU0456827905.SGD","SGXZ86797644.SGD","BK1571","BK1515","86618","BK1591"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664803883","title":"Alibaba Health Information Technology Stock Climbs 3.3% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664803883","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664803883?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:31","pubTimestamp":1788510660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Alibaba Health Information Technology Ltd. rose 3.3% to 3.14 Hong Kong dollars on what proved to be an all-around positive trading session for the Hong Kong stock market, with the Hang Seng Index rising 1.7% to 25650.87.The stock's rise snapped a four-day losing streak.Alibaba Health Information Technology Ltd. closed 60% below its 52-week high of HK$7.91, which the company reached Jan. 14.The stock outperformed some of its competitors, as HKT Trust & HKT Ltd. rose 1.4%.Trading volume totaled 67.4 million shares, compared to the 50-day average of 102.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["00241","BK1502","03037","BK1591","BK1142","BK1571","83115","02833","HHImain","HSTECH","BK1615","BK1515","BK1610","07300","03115","07200","513600","BK1589","BK1247","HSI","09115","07500","BK1584","BK1617","MCHmain","03419","82800","MHImain","HK0000165453.HKD","02800","BK1189","BK1501"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130149343","title":"DBS lifts BYD Electronic price target to HK$40, reiterates 'Buy'","url":"https://stock-news.laohu8.com/highlight/detail?id=1130149343","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130149343?lang=en_us&edition=fundamental","pubTime":"2026-09-04 16:26","pubTimestamp":1788510375,"startTime":"0","endTime":"0","summary":"DBS has released a research report stating it has raised the target price for BYD Electronic (00285) from HK$30 to HK$40, while maintaining a \"Buy\" rating. The bank has extended its valuation base to...","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1582","BK1149","BK1607","LU0348766576.USD","00285","BK1540","BK1580","BK1504","LU0348767384.USD","BK1589","EWH","BK1167","BK1515","LU0274383008.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1183163431","title":"Healthcare Sector Poised for Continued Recovery, Buoyed by Strong Innovation and Upgraded Earnings Forecasts","url":"https://stock-news.laohu8.com/highlight/detail?id=1183163431","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1183163431?lang=en_us&edition=fundamental","pubTime":"2026-09-04 15:16","pubTimestamp":1788506182,"startTime":"0","endTime":"0","summary":"According to a research report from BOCOM INTL, the Hong Kong-listed healthcare sector charted an independent course in August, with the Hang Seng Healthcare Index climbing 9.3% against a 1.2%...","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["03329","ZECP","159938","BK1161","BK1515","BK1574","09939","BK1147"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1117075643","title":"Hong Kong Stock Exchange Data Reveals Significant Custody Transfer for GENFLEET-B","url":"https://stock-news.laohu8.com/highlight/detail?id=1117075643","media":"Stock News","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1117075643?lang=en_us&edition=fundamental","pubTime":"2026-09-04 09:12","pubTimestamp":1788484341,"startTime":"0","endTime":"0","summary":"According to the latest disclosure from the Hong Kong Stock Exchange, a notable change in share custody was recorded on September 3rd for GENFLEET-B (02595). The total market value of the shares held...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1515","02595","BK1574","159938","BK1161","09939"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664028698","title":"Sino Biopharma Gets US FDA Investigational New Drug Approval for Tumor Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2664028698","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664028698?lang=en_us&edition=fundamental","pubTime":"2026-09-04 06:07","pubTimestamp":1788473269,"startTime":"0","endTime":"0","summary":"Sino Biopharmaceutical (HKG:1177) unit Chia Tai Tianqing Pharmaceutical Group obtained investigational new drug approval for TQB6426 from the U.S. Food and Drug Administration.The drug is intended for advanced malignant tumors, according to a Thursday Hong Kong bourse filing.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00BZ08YS42.EUR","01177","BK1589","BK4588","HK0000165453.HKD","IE00BZ08YR35.GBP","LABU","BK4585","BK1515","IE00BZ08YT58.USD","BK1191","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118066289","title":"Baiyunshan Announces Cash Dividend Distribution for First Half of 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=1118066289","media":"Deep News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118066289?lang=en_us&edition=fundamental","pubTime":"2026-09-03 22:41","pubTimestamp":1788446515,"startTime":"0","endTime":"0","summary":"Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited (also known as BAIYUNSHAN PH) disclosed on September 3 that it will execute its interim dividend payout for the 2026 fiscal first...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0239","BK0096","BK1191","BK1515","BK1197","BK0028","BK0097","BK0183","BK0188","BK1606","BK0012","BK0175","BK0196","BK1521","600332","BK0070","00874"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664033874","title":"Sino Biopharm Says FDA Clears IND for Tqb6426 GPC3 ADC Trial in Advanced Tumors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664033874","media":"Reuters","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664033874?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:39","pubTimestamp":1788439175,"startTime":"0","endTime":"0","summary":"Sino Biopharm says FDA clears IND for TQB6426 GPC3 ADC trial in advanced tumorsFDA granted IND clearance for TQB6426, a GPC3-targeting antibody-drug conjugate from Sino Biopharmaceutical’s Chia Tai Ti","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL2vynvZ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01177","IE00BZ08YR35.GBP","BK1191","BK1589","BK1515","HK0000165453.HKD","IE00BZ08YS42.EUR","IE00BZ08YT58.USD","BK1521"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664874083","title":"Sino Biopharmaceutical - Application for Clinical Trial on Tqb6426 \"Gpc3 ADC\" Approved by FDA","url":"https://stock-news.laohu8.com/highlight/detail?id=2664874083","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664874083?lang=en_us&edition=fundamental","pubTime":"2026-09-03 20:39","pubTimestamp":1788439159,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44V15X:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BZ08YS42.EUR","BK1521","HK0000165453.HKD","IE00BZ08YR35.GBP","BK1515","IE00BZ08YT58.USD","BK1191","BK1589","01177"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1188828400","title":"Executive Wang Lei Boosts Stake in China Resources Mixc Lifestyle with Fresh Share Purchase","url":"https://stock-news.laohu8.com/highlight/detail?id=1188828400","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1188828400?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:34","pubTimestamp":1788435276,"startTime":"0","endTime":"0","summary":"Hong Kong stock exchange filings reveal that on September 1, Wang Lei increased his holdings in CHINA RES MIXC (01209) by 50,000 shares. The transaction was executed at a price of HKD 38.52 per...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1583","00241","LU0082770016.SGD","BK1229","BK1142","LU0456846285.SGD","HK0000165453.HKD","BK1591","BK1584","BK1247","LU0164939612.USD","EWH","01209","LU0051755006.USD","BK1258","BK1542","BK1610","BK1617","LU0620787316.HKD","LU0456827905.SGD","BK1571","BK1515","BK1502","BK1189","LU0082770016.USD","BK1501","BK1615","BK1589"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1101393084","title":"GENFLEET-B Allocates HK$546,400 to Buy Back 20,000 Shares on September 3","url":"https://stock-news.laohu8.com/highlight/detail?id=1101393084","media":"Stock News","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1101393084?lang=en_us&edition=fundamental","pubTime":"2026-09-03 19:24","pubTimestamp":1788434654,"startTime":"0","endTime":"0","summary":"GENFLEET-B (02595) announced that on September 3, 2026, it spent HK$546,400 to repurchase 20,000 of its own shares.This buyback reflects the company's ongoing capital management strategy, as it...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["09939","BK1574","02595","159938","BK1161","BK1515"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878952","title":"Shanghai Fosun Pharma - Drug Registration Application for Additional Indication of Luvometinib Tablets of Unit Approved by Nmpa China","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878952","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878952?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:20","pubTimestamp":1788427213,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nFWN44U184:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK0196","BK1515","BK0060","BK0188","BK0239","02196","BK1593","BK0175","600196","BK0096","BK0028","BK0187","BK1191","BK0183","BK0012"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664878574","title":"Sihuan Pharma Affiliate Xuanzhu Biopharm Grants Innobic Exclusive Thailand Commercialization Rights for Bireociclib Tablets","url":"https://stock-news.laohu8.com/highlight/detail?id=2664878574","media":"Reuters","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664878574?lang=en_us&edition=fundamental","pubTime":"2026-09-03 17:18","pubTimestamp":1788427127,"startTime":"0","endTime":"0","summary":"Sihuan Pharma affiliate Xuanzhu Biopharm grants Innobic exclusive Thailand commercialization rights for Bireociclib tabletsSihuan Pharmaceutical’s non-wholly owned unit Xuanzhu Biopharm granted exclus","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260903:nNDL8K9jwT:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1600","BK1515","BK1593","00460","BK1191","02575"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664827084","title":"CSPC Pharmaceutical Group Stock Climbs 4.8% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664827084","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664827084?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:31","pubTimestamp":1788424260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of CSPC Pharmaceutical Group Ltd. rallied 4.8% to 9.61 Hong Kong dollars on what proved to be an all-around grim trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25213.31.The stock's rise snapped a four-day losing streak.CSPC Pharmaceutical Group Ltd. closed 17% below its 52-week high of HK$11.63, which the company achieved Sept. 9.The stock demonstrated a mixed performance when compared to some of its competitors, as Sino Biopharmaceutical Ltd. rose 6.3%, SSY Group Ltd. rose 0.2%, and United Laboratories International Holdings Ltd. rose 0.1%.Trading volume totaled 134.9 million shares, compared to the 50-day average of 105.8 million shares.Data source: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B5MMRT66.SGD","LU0067412154.USD","IE00B031HY20.USD","LU1226287792.SGD","LU1226287875.USD","LU0072913022.USD","HK0000165453.HKD","LU1813983027.USD","LU1960683339.HKD","LU1993786604.SGD","KURE","LU1807302812.USD","IE00BZ08YR35.GBP","IE00BZ08YT58.USD","LU1226288170.HKD","LU1226287529.USD","LU1226288253.USD","BK1521","01093","LU0140636845.USD","LU1152091168.USD","SG9999004220.SGD","LU1152091754.HKD","LU0326950275.SGD","BK1191","LU1008478684.HKD","IE00BZ08YS42.EUR","LU2039709279.SGD","IE0008368742.USD","LU0314109678.HKD","LU1328277881.USD","IE0008369823.USD","LU0501845795.SGD","LU0315179316.USD","LU0880133367.SGD","BK1515","LU1951186391.HKD","IE00B543WZ88.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664482770","title":"Sino Biopharmaceutical Stock Rises 6.3% in Hong Kong, Outperforms Competitors","url":"https://stock-news.laohu8.com/highlight/detail?id=2664482770","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664482770?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:31","pubTimestamp":1788424260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of Sino Biopharmaceutical Ltd. rallied 6.3% to 5.59 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25213.31.Sino Biopharmaceutical Ltd. closed 39% below its 52-week high of HK$9.12, which the company reached Sept. 10.The stock outperformed some of its competitors, as CSPC Pharmaceutical Group Ltd. rose 4.8% and Amgen Inc. remained unchanged.Trading volume totaled 127.7 million shares, compared to the 50-day average of 101.5 million shares.Data source: Dow Jones Market Data, FactSet","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BZ08YS42.EUR","LU0320765992.SGD","BK4533","BK1515","LU0889565916.HKD","IBB","BK1521","01177","BK4585","IE0002141913.USD","BK4581","AMGN","IE00BZ08YT58.USD","LU0109394709.USD","BK4139","PBE","LU1983299246.USD","BK4566","IE00BJT1NW94.SGD","SG9999001440.SGD","LU2242646821.SGD","PJP","HK0000165453.HKD","IE00B4R5TH58.HKD","LU2089984988.USD","LU1023059063.AUD","IBBQ","IE00BZ08YR35.GBP","BIB","LU0868494617.USD","TBXU","IE00BFTCPJ56.SGD","BBH","LU1061106388.HKD","IE0009355771.USD","LU2112291526.USD","LU1057294990.SGD","LU1571399168.USD","LU0122379950.USD","BK1589","IE00B2B36J28.USD","BK1191","LU2468319806.SGD","LU0289739699.SGD","BK4534","BK4599","IE00BJJMRZ35.SGD","LU0058720904.USD","LU2242652126.USD","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664038827","title":"BYD Electronic (International) Stock Falls 3.1% in Hong Kong","url":"https://stock-news.laohu8.com/highlight/detail?id=2664038827","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2664038827?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:31","pubTimestamp":1788424260,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.Shares of BYD Electronic  Co. Ltd. slipped 3.1% to 25.00 Hong Kong dollars on what proved to be an all-around poor trading session for the Hong Kong stock market, with the Hang Seng Index falling 0.4% to 25213.31.This was the stock's third consecutive day of losses.BYD Electronic  Co. Ltd. closed 44% short of its 52-week high of HK$44.60, which the company achieved Oct. 2.Despite its losses, the stock outperformed some of its competitors, as Times Universal Group Holdings Ltd. fell 4.0%.Trading volume totaled 9.2 million shares, compared to the 50-day average of 12.7 million shares.Data source: Dow Jones Market Data, FactSet","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK1167","BK1540","00285","BK1582","BK1504","BK1607","LU0274383008.USD","BK1589","BK1149","BK1515","BK1580","LU0348766576.USD","LU0348767384.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1168391109","title":"Shanghai Fosun Pharmaceutical Secures Regulatory Nod for Expanded Use of Lung Cancer Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=1168391109","media":"Stock News","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1168391109?lang=en_us&edition=fundamental","pubTime":"2026-09-03 16:26","pubTimestamp":1788423987,"startTime":"0","endTime":"0","summary":"Shanghai Fosun Pharmaceutical (Group) Co., Ltd. has announced that its majority-owned subsidiary, Shanghai Fosun Pharmaceutical Industrial Development Co., Ltd., recently received approval from the...","market":"nz","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0060","BK0096","600196","BK0012","BK1593","BK1515","BK1191","BK0183","BK0239","BK0196","BK0187","BK0175","BK0188","BK0028","02196"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":5,"totalSize":200,"code":"91000000","status":"200"}]}}